Pre-treatment haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer

Journal of International Medical Research

Volumn 33, Issue 3, 2005, Pages 319-328

  Kandemir, E Gokhan ^a   Mayadagli, A ^a   Turken, O ^a   Yaylaci, M ^a   Ozturk, A ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Anaemia; Breast cancer; Haemoglobin concentration; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; HEMOGLOBIN; HORMONE DERIVATIVE; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; ANEMIA; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; TUMOR VOLUME;

EID: 19644397940     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300307     Document Type: Article

References (33)

1. Mercadante S, Gebbia V, Marrazzo A, Filosto S: Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev 2000; 26: 303-311.
2. Groopman JE, Itri LM: Chemotherapy-induced anaemia in adults: incidence and treatment. J Natl Cancer Inst 1999; 91: 1616-1634.
3. Bron D, Meuleman N, Mascaux C: Biological basis of anaemia. Semin Oncol 2001; 28: 1-6.
4. Ludwig H: Epoetin in cancer-related anaemia. Nephrol Dial Transplant 1999; 14: 85-92.
5. Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, et al: Anaemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998; 42: 1069-1075.
6. Wagner W, Hermann R, Hartlapp J, Esser E, Christoph B, Muller MK, et al: Prognostic value of haemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery. Strahlenther Onkol 2000; 176: 73-80.
7. Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, et al: The importance of haemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999; 86: 1528-1536.
8. Caro JJ, Salas M, Ward A, Goss G: Anaemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001; 91: 2214-2221.
9. Kirshner J, Hatch M, Hennessy DD, Fridman M, Tannous RE: Anaemia in stage II and III breast cancer patients treated with adjuvant doxorubicin and cyclophosphamide chemotherapy. Oncologist 2004; 1: 25-32.
10. Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M: Blood haemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol 2004; 180: 45-51.
11. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P: Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56: 4509-4515.
12. Vaupel P, Thews O, Kelleher DK, Hoeckel M: Oxygenation of human tumours: the Mainz experience. Strahlenther Onkol 1998; 174: 6-12.
13. Hockel M, Vaupel P: Biological consequences of tumour hypoxia. Semin Oncol 2001; 28: 36-41.
14. Reynolds TY, Rockwell S, Glazer PM: Genetic instability induced by the tumour microenvironment. Cancer Res 1996; 56: 5754-5757.
15. Reiher FK, Ivanovich M, Huang H, Smith ND, Bouck NP, Campbell SC: The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer. J Urol 2001; 165: 2075-2081.
16. Young SD, Marshall RS, Hill RP: Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumour cells. Proc Natl Acad Sci U S A 1988; 85: 9533-9537.
17. Bottini A, Berruti A, Brizzi MP, Bersiga A, Generali D, Allevi G, et al: Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer. Br J Cancer 2003; 89: 977-982.
18. Hockel M, Schlenger K, Hockel S: Association between tumour hypoxia and malignant progression: the clinical evidence in cancer of the uterine cervix. In: Tumour Hypoxia (Vaupel P, Kelleher DK, eds). Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1999; pp65-74.
19. Vaupel P, Mayer A, Briest S, Hockel M: Oxygenation gain factor: a novel parameter characterizing the association between haemoglobin level and the oxygenation status of breast cancers. Cancer Res 2003; 63: 7634-7637.
20. Rice GC, Hoy C, Schimke RT: Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci U S A 1986; 83: 5978-5982.
21. Russo CA, Weber TK, Volpe CM, Stoler DL, Petrelli NJ, Rodriguez-Bigas M: An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. Cancer Res 1995; 55: 1122-1128.
22. Hockel M, Schlenger K, Hockel S, Vaupel P: Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 1999; 59: 4525-4528.
23. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
24. Wilson RE, Keng PC, Sutherland RM: Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia. J Natl Cancer Inst 1989; 81: 1235 -1240.
25. Mattern J, Kallinowski F, Herfarth C, Volm M: Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer 1996; 67: 20-23.
26. Hartmann A Kunz M, Kostlin S, Gillitzer R, Toksoy A, Brocker EB, et al: Hypoxia-induced upregulation of angiogenin in human malignant melanoma. Cancer Res 1999; 59: 1578-1583.
27. Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S: Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999; 80: 617-623.
28. Dunst J, Pigorsch S, Hansgen G, Hintner I, Lautenschlager C, Becker A: Low haemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anaemia stimulate angiogenesis? Strahlenther Onkol 1999; 175: 93-96.
29. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, et al: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88-91.
30. Gatenby RA, Kessler HB, Rosenblum JS, Loia LR, Moldofsky PJ, Hartz WH, et al: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988; 14: 831-838.
31. Hasan NM, Adams GE, Joiner MC, Marshall JF, Hart IR: Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability. Br J Cancer 1998; 77: 1799-1805.
32. Hall EJ: The oxygen effect and reoxygenation. In: Radiobiology for the radiologist, 4th edn (Hall E, ed). Philadelphia, PA: Lippincott, Williams & Wilkins, 1994; pp133-152.
33. Schrijvers D, Highley M, De Bruyn E, Van Oosterom AT, Vermorken JB: Role of red blood cells in pharmacokinetics of chemotherapeutic agents. Anticancer Drugs 1999; 10: 147-153.